Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation

Enhancer of zeste homolog 2 (EZH2), which is overexpressed in a wide range of tumors, contributes to ovarian cancer malignancy in several different ways. We aimed to illustrate the role of EZH2 in ovarian cancer cisplatin resistance and to identify possible underlying mechanisms of this role that ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Si, Zhao, Simei, Yang, Qiang, Wang, Wenwen, Cai, E, Wen, Yiping, Yu, Lili, Wang, Zehua, Cai, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989839/
https://www.ncbi.nlm.nih.gov/pubmed/29630768
http://dx.doi.org/10.1111/cas.13599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989839/
https://www.ncbi.nlm.nih.gov/pubmed/29630768
http://dx.doi.org/10.1111/cas.13599

Ejemplares similares